KemPharm Logo
KemPharm's KP201/APAP Featured at the 2015 Abuse Deterrent Formulations Summit
May 19, 2015 16:05 ET | KemPharm
CORALVILLE, Iowa, May 19, 2015 (GLOBE NEWSWIRE) -- KemPharm, Inc. (Nasdaq:KMPH), a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary new molecular...
KemPharm Logo
KemPharm, Inc. to Report Q1 2015 Results
May 18, 2015 16:02 ET | KemPharm
CORALVILLE, Iowa, May 18, 2015 (GLOBE NEWSWIRE) -- KemPharm, Inc. (Nasdaq:KMPH), a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary new molecular...
KemPharm Logo
KemPharm Announces Pricing of Initial Public Offering
April 15, 2015 21:11 ET | KemPharm
CORALVILLE, Iowa, April 15, 2015 (GLOBE NEWSWIRE) -- KemPharm, Inc., a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary new molecular entity...
KemPharm Logo
KemPharm, Inc. Presents Key Findings for Novel Hydromorphone Prodrug at 2012 International Conference on Opioids
June 11, 2012 08:16 ET | KemPharm
NORTH LIBERTY, Iowa, June 11, 2012 (GLOBE NEWSWIRE) -- KemPharm, Inc. today presented key preclinical findings from KP511, the Company's first-in-class oral hydromorphone prodrug, at the 2012...
KemPharm Logo
KemPharm Inc. Focuses on Advanced Pain Management Franchise
May 22, 2012 08:01 ET | KemPharm
NORTH LIBERTY, Iowa, May 22, 2012 (GLOBE NEWSWIRE) -- KemPharm, Inc. ("KemPharm"), a clinical-stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat...
KemPharm Logo
KemPharm, Inc. Expands Pain Therapy Pipeline With Discovery of KP511
October 26, 2011 08:05 ET | KemPharm
NORTH LIBERTY, Iowa, Oct. 26, 2011 (GLOBE NEWSWIRE) -- KemPharm, Inc. today announced it plans to initiate development of its recently identified lead compound KP511, a first-in-class oral prodrug of...
KemPharm Logo
KemPharm, Inc. Expands ADHD Pipeline With Discovery of KP415
August 30, 2011 08:11 ET | KemPharm
NORTH LIBERTY, Iowa, Aug. 30, 2011 (GLOBE NEWSWIRE) -- KemPharm, Inc. ("KemPharm") today announced it plans to initiate development of its recently identified lead compound KP415, a first-in-class...